Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trends in medicinal chemistry.

D Cavalla1, J Gilmore

  • 1Arachnova Ltd., St. John's Innovation Centre, Cambridge, UK.

Drug News & Perspectives
|December 24, 2004
PubMed
Summary

Researchers explored emerging medicinal chemistry trends and novel drug candidates for various diseases. Key discoveries included new treatments for CNS disorders, immune diseases, cancer, and cardiovascular conditions, highlighting future therapeutic approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Pharmaceutical Research

Background:

  • The Society for Medicines Research convened a meeting on "Trends in Medicinal Chemistry" in London.
  • The meeting aimed to inform researchers about early-stage compounds and new discoveries with potential for future disease treatment.

Purpose of the Study:

  • To present and discuss novel compounds and therapeutic strategies across diverse medical fields.
  • To highlight advancements in drug development for central nervous system (CNS) disorders, immune diseases, cancer, and cardiovascular diseases.

Main Methods:

  • Presentations by researchers on compounds in early development.
  • Discussion of new discoveries and their potential therapeutic applications.
  • Focus on a wide range of therapeutic areas and specific drug candidates.

Main Results:

  • Several novel compounds were described, including antipsychotic (ORG-23366), anticonvulsant (SB-204269, SB-258229, SB-270664), and antimigraine agents (L-775606, L-785103).
  • Tyrosine kinase inhibitors (CT-5269, CT-4694), VEGF inhibitors, an elastase inhibitor (GW-311616A), a serine protease inhibitor, and an MMP inhibitor (D-2163) were presented.
  • New P(2T) inhibitors (AR-C69931MX) and a phosphodiesterase type 5 (PDE5) inhibitor (sildenafil) were also detailed.

Conclusions:

  • The meeting showcased significant progress in medicinal chemistry, offering promising avenues for future therapies.
  • The diverse range of compounds discussed indicates a vibrant pipeline for treating complex diseases.
  • These advancements underscore the rapid evolution of drug discovery and development in addressing unmet medical needs.

Related Experiment Videos